Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Clinical Importance of Insulin Resistance & Steroid-Associated Hyperglycemia in Relapsing Multiple Sclerosis

NCT03004079 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT03004079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03004079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Clinical Importance of Insulin Resistance & Steroid-Associated Hyperglycemia in Relapsing Multiple Sclerosis
Lead sponsor
University of Virginia
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2016
Completion date
September 30, 2020
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinically isolated syndrome, relapsing remitting multiple sclerosis